Cart
sales@molnova.com
Co 102862
CAS No. 181144-66-1
Co 102862( V 102862 )
Catalog No. M27616 CAS No. 181144-66-1
Co 102862 is a voltage-gated sodium channel blocker. Co 102862 can be used for anticonvulsant studies.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 46 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 42 | In Stock |
|
| 10MG | 69 | In Stock |
|
| 25MG | 140 | In Stock |
|
| 50MG | 212 | In Stock |
|
| 100MG | 346 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCo 102862
-
NoteResearch use only, not for human use.
-
Brief DescriptionCo 102862 is a voltage-gated sodium channel blocker. Co 102862 can be used for anticonvulsant studies.
-
DescriptionCo 102862 is a voltage-gated sodium channel blocker. Co 102862 can be used for anticonvulsant studies.
-
In Vitro——
-
In Vivo——
-
SynonymsV 102862
-
PathwayOthers
-
TargetOther Targets
-
RecptorTNF-α
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number181144-66-1
-
Formula Weight273.267
-
Molecular FormulaC14H12FN3O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 41.67 mg/mL (152.49 mM)
-
SMILESNC(=O)N\N=C\c1ccc(Oc2ccc(F)cc2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ma L, et al. A novel small-molecule tumor necrosis factor α inhibitor attenuates inflammation in a hepatitis mouse model. J Biol Chem. 2014 May 2;289(18):12457-66.
molnova catalog
related products
-
2-Fluorothymidine
2'-Fluorothymidine (2'-Deoxy-2'-fluoro-5-Methyluridine) belongs to the thymidine (TdR) and methyluridine isozymes and is a highly selective substrate for thymidine kinase type 2 (TK2).
-
1-Stearoyl-sn-glycer...
1-Stearoyl-sn-glycero-3-phosphocholine?is a chemical used in lipid metabolism studies.
-
BI-0474
BI-0474 is a potent KRASG12C inhibitor that inhibits GDP-KRAS::SOS1 protein-protein interactions with an IC50 value of 7.0 nM.BI-0474 exhibits significant antiproliferative activity against NCI-H358 cells harboring the G12C mutation, and shows significant anti-tumor activity in a non-small cell lung cancer xenograft model.
